Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen T Abedon

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
The ISME Journal|March 15, 2017
Lysogeny in nature: mechanisms, impact and ecology of temperate phagesCristina Howard-Varona, Katherine R Hargreaves, Stephen T Abedon, et al.
Bacteriophage|February 16, 2012
Phage treatment of human infectionsStephen T Abedon, Sarah J Kuhl, Bob G Blasdel, et al.
Viruses|July 2, 2021
Improving Phage-Biofilm In Vitro ExperimentationStephen T Abedon, Katarzyna M Danis-Wlodarczyk, Daniel J Wozniak, et al.
Emerging Infectious Diseases|October 22, 2004
Human Escherichia coli O157:H7 genetic marker in isolates of bovine originJeffrey T Lejeune, Stephen T Abedon, Kaori Takemura, et al.
Plos Biology|May 23, 2023
Translating phage therapy into the clinic: Recent accomplishments but continuing challengesAleksandra Petrovic Fabijan, Jonathan Iredell, Katarzyna Danis-Wlodarczyk, et al.
Current Pharmaceutical Biotechnology|March 11, 2010
Phage therapy in clinical practice: treatment of human infectionsElizabeth Kutter, Daniel De Vos, Guram Gvasalia, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2021
Friends or Foes? Rapid Determination of Dissimilar Colistin and Ciprofloxacin Antagonism of <i>Pseudomonas aeruginosa</i> PhagesKatarzyna M Danis-Wlodarczyk, Alice Cai, Anna Chen, et al.
Antibiotics (Basel, Switzerland)|November 21, 2018
Fighting Fire with Fire: Phage Potential for the Treatment of <i>E. coli</i> O157 InfectionCristina Howard-Varona, Dean R Vik, Natalie E Solonenko, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
The ISME Journal|March 15, 2017
Lysogeny in nature: mechanisms, impact and ecology of temperate phagesCristina Howard-Varona, Katherine R Hargreaves, Stephen T Abedon, et al.
Bacteriophage|February 16, 2012
Phage treatment of human infectionsStephen T Abedon, Sarah J Kuhl, Bob G Blasdel, et al.
Viruses|July 2, 2021
Improving Phage-Biofilm In Vitro ExperimentationStephen T Abedon, Katarzyna M Danis-Wlodarczyk, Daniel J Wozniak, et al.
Emerging Infectious Diseases|October 22, 2004
Human Escherichia coli O157:H7 genetic marker in isolates of bovine originJeffrey T Lejeune, Stephen T Abedon, Kaori Takemura, et al.
Plos Biology|May 23, 2023
Translating phage therapy into the clinic: Recent accomplishments but continuing challengesAleksandra Petrovic Fabijan, Jonathan Iredell, Katarzyna Danis-Wlodarczyk, et al.
Current Pharmaceutical Biotechnology|March 11, 2010
Phage therapy in clinical practice: treatment of human infectionsElizabeth Kutter, Daniel De Vos, Guram Gvasalia, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2021
Friends or Foes? Rapid Determination of Dissimilar Colistin and Ciprofloxacin Antagonism of <i>Pseudomonas aeruginosa</i> PhagesKatarzyna M Danis-Wlodarczyk, Alice Cai, Anna Chen, et al.
Antibiotics (Basel, Switzerland)|November 21, 2018
Fighting Fire with Fire: Phage Potential for the Treatment of <i>E. coli</i> O157 InfectionCristina Howard-Varona, Dean R Vik, Natalie E Solonenko, et al.
Pageof 7